BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 4:06:00 PM | Browse: 614 | Download: 725
Publication Name World Journal of Gastroenterology
Manuscript ID 6611
Country Spain
Received
2013-10-25 14:20
Peer-Review Started
2013-10-25 19:24
To Make the First Decision
2013-12-26 11:17
Return for Revision
2013-12-26 20:43
Revised
2014-01-15 20:54
Second Decision
2014-04-09 08:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 08:52
Articles in Press
2014-05-23 10:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-12 19:48
Publish the Manuscript Online
2014-07-26 13:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights
Manuscript Source Invited Manuscript
All Author List Carlos Sostres, Carla Jerusalen Gargallo and Angel Lanas
Funding Agency and Grant Number
Corresponding Author Angel Lanas, MD, DSc, Clinical Chief, Professor, Service Department of Digestive Diseases, University Hospital Lozano Blesa, c/Domingo Miral s/n, 50009 Zaragoza, Spain. alanas@unizar.es
Key Words Nonsteroidal anti-inflammatory drugs; Low dose aspirin; Helicobacter pylori infection; Helicobacter pylori eradication; Peptic ulcer disease
Core Tip Helicobacter pylori (H. pylori) infection, nonsteroidal anti-inflammatory drugs (NSAID) or low dose aspirin use independently increases the risk for the development of peptic ulcer disease. In clinical practice, the presence of H. pylori infection associated with low dose aspirin and/or NSAID use in the same patient is becoming more frequent and therefore the potential interaction between these factors and the consequences of it has important implications. In real clinical practice, we can find different clinical scenarios involving these three factors associated with the presence of different gastrointestinal and cardiovascular risk factors. These huge variety of possible combinations greatly hinder the decision making process of physicians.
Publish Date 2014-07-26 13:36
Citation Sostres C, Gargallo CJ, Lanas A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights. World J Gastroenterol 2014; 20(28): 9439-9450
URL http://www.wjgnet.com/1007-9327/full/v20/i28/9439.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i28.9439
Full Article (PDF) WJG-20-9439.pdf
Full Article (Word) WJG-20-9439.doc
Manuscript File 6611-Review.doc
Answering Reviewers 6611-Answering reviewers.pdf
Copyright License Agreement 6611-Copyright assignment.PDF
Peer-review Report 6611-Peer review(s).pdf
Scientific Editor Work List 6611-Scientific editor work list.doc